Canada’s leading
Pharmaceutical
market access
strategy
consultancy
Our team of experts use their unique combination of real-world experience, technical skill, and nuanced understanding of the Canadian payer context to provide honest and practical guidance to our clients on navigating the market’s complexities.
We partner with clients throughout the entire product lifecycle—from early-stage evidence development and strategy to reimbursement and post-market processes—delivering tailored, high-quality solutions that address each client’s unique needs. By integrating insights of key stakeholders across the healthcare ecosystem, we ensure our strategies drive meaningful impact and support long-term success.
MORSE Services
We focus on being our Clients’ Strategy partner across the product’s life cycle from early-stage evidence strategy through reimbursement and post-market processes, complementing and enhancing the technical work done by submission dossier vendors. Our unique perspective and insights enable us to deliver tailored strategies that effectively engage key stakeholders in the healthcare ecosystem.
Comprehensive Market Access Launch Strategy
We provide specifically tailored support to help you ASSESS the landscape, MITIGATE risks, and OPTIMIZE market access success for your drugs, particularly for complex drugs including specialty, oncology and drugs for rare disease (DRDs). Our guidance will help you navigate the complexities of the Canadian healthcare system.
Market Access Landscape Analysis
We provide you with the insights needed to INFORM your strategy throughout your product launch life cycle. Our comprehensive analysis will equip you with a clear understanding of the market dynamics, facilitating informed decision-making.
HTA Planning and Reimbursement Evidence Strategy
Our real-world experience, technical skill, and nuanced understanding of the Canadian payer & HTA context enable us to provide expert guidance on HTA assessment and (re)submission strategies throughout your product launch life cycle. We ensure your product is well-positioned for success.
Negotiation & Stakeholder Engagement Strategy
Our unique understanding of Canadian payers will help you OPTIMIZE your approach, VALIDATE your position, and NAVIGATE challenges in negotiations with the pCPA and private payers. We serve as your trusted partner in fostering productive relationships with key stakeholders.
Portfolio & Life Cycle Strategy
Our deep expertise and unique insights into the Canadian market access landscape allow us to help you proactively PLAN and optimize your portfolio & life cycle challenges. Our strategic approach will help you maintain a strong market presence and adapt to evolving conditions.
Expert-Led Training & Customized Workshops
Our unparalleled expertise in the Canadian market access landscape enables us to offer a comprehensive suite of training programs and customized interactive workshops designed to PREPARE your team for success. We will equip your team with the knowledge and skills necessary to thrive in this dynamic environment.
MORSE Values
EXCELLENCE
We prioritize our team’s welfare and the quality of services and products we deliver to our clients while constantly looking for ways to improve.
INTEGRITY
We choose actions that reflect honesty and fairness: we honour our commitments and acknowledge our mistakes.
RESPECT
We communicate with openness, authenticity, kindness and respect and value the time, capability and intentions of everyone we work with.
COLLABORATION
We achieve success by building meaningful relationships and openly collaborating in the pursuit of excellence.
EXCELLENCE
We prioritize our team’s welfare and the quality of services and products we deliver to our clients while constantly looking for ways to improve.
INTEGRITY
We choose actions that reflect honesty and fairness: we honour our commitments and acknowledge our mistakes.
RESPECT
We communicate with openness, authenticity, kindness and respect and value the time, capability and intentions of everyone we work with.
COLLABORATION
We achieve success by building meaningful relationships and openly collaborating in the pursuit of excellence.
MORSE Reports
2024 edition of the Canadian Reimbursement and Forecasting Timelines (CRaFT) subscription, the new Drugs for Rare Diseases (DRD) Sub-Report and Oncology Market Access Trends & Insights report!
MORSE Signals
Timely and relevant updates related to the emerging developments in the Canadian pharmaceutical reimbursement landscape.
MORSE Careers
